Results
1 -
10 of
10What Are the Promising New Therapies in the Field of Chronic Hepatitis C After the First-Generation Direct-Acting Antivirals?, Current Gastroenterology Reports Antiviral drugs against hepatitis C virus, Genetic Vaccines and Therapy New developments in small molecular compounds for anti-hepatitis C virus (HCV) therapy, Journal of Zhejiang University SCIENCE B Naturally occurring resistance mutations to inhibitors of HCV NS5A region and NS5B polymerase in DAA treatment-na??ve patients, Virology Journal Characterization of interactions between hepatitis C virus NS5B polymerase, annexin A2 and RNA u2013 effects on NS5B catalysis and allosteric inhibition, Virology Journal A recent report has predicted that hepatitis C virus (HCV) drug sales will almost quadruple by 2013, across major markets, PharmacoEconomics & Outcomes News Johnson, Sarah; Drowns, Matt; Tatlock, John; Linton, Angelica; Gonzalez, Javier; Hoffman, Robert; Jewell, Tanya; Patel, Leena; Blazel, Julie; Tang, Mingnam; Li, Hui.
Synthetic Route Optimization of PF-00868554, An HCV Polymerase Inhibitor in Clinical Evaluation, Synlett 2010, 796-800